<dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
<cite id="ilis8"><option id="ilis8"></option></cite>
    1. <ul id="ilis8"></ul>
  1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
    歡迎光臨:萊耀標(biāo)準(zhǔn)品網(wǎng)!
    ?您的位置:對(duì)照品 > 試劑耗材 > 生化試劑 >
    Vc-MMAD, ≥99%
    產(chǎn)品基本信息
    產(chǎn)品編號(hào):125316
    產(chǎn)品名稱:Vc-MMAD, ≥99%
    產(chǎn)品CAS:1401963-17-4
    規(guī)格含量:5MG
    產(chǎn)品價(jià)格:5000
    聯(lián)系我們:
    產(chǎn)品詳細(xì)介紹

      Vc-MMAD, ≥99%

      Product Name: Vc-MMAD
      CAS號(hào):1401963-17-4
      分子式:C70H104N12O14S
      分子量:1369.71
      貯存: 儲(chǔ)存溫度-20°C
      可溶性: 25°C: DMSO
      生化和生理學(xué)機(jī)理:
      Description:
      Monomethyl auristatin D (MMAD), a potent tubulin inhibitor, is a toxin payload and antibody drug conjugate.
      For comparison purposes, the ADC A1 -mc-MMAD and/or A1 -vc-MMAD were used. The linker payload, mc-MMAD (6-maleimidocaproyl-monomethylauristatin-D) was conjugated to the A1 anti-5T4 monoclonal antibody through a cysteine residue at a ratio of approximately 4 drug moieties per antibody molecule. The linker payload mc- Val-Cit-PABVIP(LA)MMAD or vc-MMAD (maleimidocapronic -valine-citruline-p- aminobenzyloxycarbonyl- monomethylauristatin-D) was conjugated to the A1 anti-5T4 monoclonal antibody through a cysteine residue at a ratio of approximately 4 drug moieties per antibody molecule (Antibody-drug conjugates Patent: WO 2013068874 A1).


    2011-2018 信陽(yáng)萊耀生物科技有限公司 @ 信陽(yáng)埃爾文生物科技有限公司版權(quán)所有

    中檢所標(biāo)準(zhǔn)品,對(duì)照品,標(biāo)準(zhǔn)氣體
    Keywords: 中檢所標(biāo)準(zhǔn)品 對(duì)照品 標(biāo)準(zhǔn)氣體
    <dl id="ilis8"></dl><strike id="ilis8"><option id="ilis8"><em id="ilis8"></em></option></strike>
    <cite id="ilis8"><option id="ilis8"></option></cite>
      1. <ul id="ilis8"></ul>
    1. <blockquote id="ilis8"><strong id="ilis8"></strong></blockquote>
      红桃视频在线观看一区二区三区 | 蜜桃视频在线观看视频 | 波多野结衣毛片 | 天天狠天天爽视频 | 刘晓庆脱了内裤让人看照片 |